John Powers, co-founder and President of Murrieta Genomics, LLC, the Southern California genomic sequencing business incubator, is pleased to announce
Blog
During our grand opening in August, we took the time to interview many of our partners and supporters. The interviews
Want curated biotech news? I get dozens of newsletters every day that keep me informed on what's happening in biotech.
I read a great blog post in Technology Networks today by Aaron Hudson of SCIEX. He writes about how multi-omic
Press Releases
“The simplSEQ workflow offers many workflow advantages over other methods of cell-free DNA extraction especially speed, simplicity, reproducibility, which are
Company Filed Second Patent Application to Extend Core Technology Applications
Murrieta Genomics is pleased to announce that U.S. Patent and Trademark
Murrieta Genomics, the launch pad for genomic sequencing startups, is pleased to announce that simplSEQ, an incubator company and subsidiary,
“Our first product is a kit for the purification and isolation of nucleic acids from plasma that we believe will
Blog
John Powers, co-founder and President of Murrieta Genomics, LLC, the Southern California genomic sequencing business incubator, is pleased to announce
During our grand opening in August, we took the time to interview many of our partners and supporters. The interviews
Want curated biotech news? I get dozens of newsletters every day that keep me informed on what's happening in biotech.
I read a great blog post in Technology Networks today by Aaron Hudson of SCIEX. He writes about how multi-omic
Press Releases
“The simplSEQ workflow offers many workflow advantages over other methods of cell-free DNA extraction especially speed, simplicity, reproducibility, which are
Company Filed Second Patent Application to Extend Core Technology Applications
Murrieta Genomics is pleased to announce that U.S. Patent and Trademark
Murrieta Genomics, the launch pad for genomic sequencing startups, is pleased to announce that simplSEQ, an incubator company and subsidiary,
“Our first product is a kit for the purification and isolation of nucleic acids from plasma that we believe will